Article
Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Thrombosis research - 1 Jan 2007
Schöni Reto, Quehenberger Peter, Wu Jogin R, Wilmer Marianne
Abstract excerpt
A new clotting assay, Pefakit APC-R Factor V Leiden (Pentapharm Ltd., Switzerland), for the detection of an increased resistance of coagulation factor V against degradation by activated protein C, caused mainly by the factor V Leiden mutation, was evaluated in clinical studies at two University Centers in Europe and the US. The performance was compared with the performance of the routinely used predicate device...
Topics
- Activated Protein C Resistance
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Chemistry, Clinical
- Child
- Europe
- Factor V
- Female
- Humans
- Male
- Middle Aged
- Mutation
- Prothrombin
- Sensitivity and Specificity
- Thrombophilia
- United States